MFDs का SETUFree Financial Toolkit

ICICI Prudential Nifty Pharma Index Fund

Factual scheme page. Every figure below is as reported by the data source on the date shown, and is a record of the past — not a forecast and not a promise.

  • Latest NAV: ₹20.5529 (as on 3 Nov 2026)
  • Fund house: ICICI Prudential Mutual Fund
  • Category: Other Scheme - Index Funds
  • Plan: Regular Plan
  • Option: Growth
  • AUM: ₹148 crore
  • Expense ratio: 1.13%
  • Benchmark: Nifty Pharma TRI
  • Riskometer: Very High Risk
  • Inception: 25 Nov 2022
  • Exit load: Nil

Returns as reported (CAGR)

  • 1 year: 20.64%
  • 3 years: 21.60%
  • Since inception: 20.55%

Mutual fund investments are subject to market risks. Read all scheme related documents carefully. Past performance is not indicative of future returns. Aumsetu publishes scheme facts and does not rate, rank or recommend any scheme.

Fund Explorer · Screener · Compare schemes · All fund houses